Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1981 1
1983 2
1984 2
1986 3
1987 1
1988 1
1989 2
1992 2
2000 1
2007 2
2008 3
2009 9
2010 11
2011 7
2012 11
2013 11
2014 13
2015 11
2016 6
2017 4
2018 4
2019 3
2020 16
2021 16
2022 14
2023 20
2024 9
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
An RNA transmethylation pathway governs kidney nephrogenic potential.
Ramalingam H, Alvarez J, Flaten A, Cobo-Stark P, Foster N, Grilli E, Lakhia R, Aboudehen K, Carroll T, Patel V. Ramalingam H, et al. Among authors: grilli e. Nat Commun. 2025 May 28;16(1):4930. doi: 10.1038/s41467-025-60097-6. Nat Commun. 2025. PMID: 40436842 Free PMC article.
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21.
Fabeni L, Armenia D, Abbate I, Gagliardini R, Mazzotta V, Bertoli A, Gennari W, Forbici F, Berno G, Piermatteo L, Borghi V, Pinnetti C, Vergori A, Mondi A, Parruti G, Di Sora F, Iannetta M, Lichtner M, Latini A, Mussini C, Sarmati L, Perno CF, Girardi E, Antinori A, Ceccherini-Silberstein F, Maggi F, Santoro MM; Italian HIV Drug Resistance Group. Fabeni L, et al. J Antimicrob Chemother. 2024 Sep 3;79(9):2152-2162. doi: 10.1093/jac/dkae189. J Antimicrob Chemother. 2024. PMID: 39028674 Free PMC article.
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study).
Gagliardini R, Camici M, Lanini S, Bellagamba R, Ottou S, Plazzi MM, Vergori A, Mazzotta V, Mondi A, Fusto M, Paulicelli J, Tempestilli M, Pinnetti C, Grilli E, Mastrorosa I, De Zottis F, Duca GD, Antinori A. Gagliardini R, et al. Among authors: grilli e. Int J Infect Dis. 2025 Sep;158:107961. doi: 10.1016/j.ijid.2025.107961. Epub 2025 Jun 18. Int J Infect Dis. 2025. PMID: 40541768 Free article.
Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognition.
Vergori A, Del Duca G, Lorenzini P, Brita AC, Mastrorosa I, Fusto M, Camici M, Ottou S, Gagliardini R, Paulicelli J, De Zottis F, Grilli E, Esvan R, Plazzi MM, Mazzotta V, Bellagamba R, Antinori A, Pinnetti C. Vergori A, et al. Among authors: grilli e. AIDS. 2025 Mar 1;39(3):270-275. doi: 10.1097/QAD.0000000000004043. Epub 2024 Oct 24. AIDS. 2025. PMID: 39453875 Free PMC article.
174 results